Novo Nordisk A/S (NYSE:NVO) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Novo Nordisk A/S (NYSE:NVO) ...

More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...

If you’re pregnant or hoping to become pregnant, it’s natural to have questions about your medications. And if you’re taking ...

A new study has revealed what could be happening to your muscles after taking Ozempic, though clinical trials are needed to test on humans ...

A UK government and Eli Lilly £85 million program will expand obesity care nationwide, offering digital, community, and ...

On this news, Novo Nordisk's stock price fell $15.06, or 21.8%, to close at $53.94 per share on July 2, 2025, thereby injuring investors. What Is The Lawsuit About?

July, video editor Meng Meng, 38, has been injecting herself with a weekly weight loss drug, hoping it will finally help her ...

Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage diabetes and obesity around the world. Collectively known as GLP-1 agonists, ...

And it’s a problem with humankind in general. We do tend to crave quick fixes, often in pharmaceutical form. That’s why Henry Dimbleby, a food campaigner and founder of Leon, called Ozempic “the ...

As new therapies for obesity enter the market, biopharmaceutical companies will need to tune commercial strategies to win ...

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...